Physician profile
Michael Robert Koerner
NPI 1255779567
$3,536.11
in general payments reported to CMS, 2019-2025
13 companies · $91.14 in 2025
The $91.14 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $521 · 2020: $179 · 2021: $333 · 2022: $154 · 2023: $2,241 · 2024: $16.21 · 2025: $91.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,642 · Food and Beverage: $707.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,641.57 |
| Food and Beverage | $706.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,674.19 | 2023 | |
| Depuy Synthes Sales INC. | $663.45 | 2019-2025 | Na, Orthovisc, Monovisc |
| Stryker Corporation | $388.30 | 2019-2025 | T2 |
| Illuminoss Medical, INC. | $169.97 | 2023-2025 | Photodynamic Bone Stabilization Procedure Pack |
| Curvafix, INC. | $157.00 | 2023 | Curvafix Im Implant |
| Abiomed | $135.00 | 2021 | |
| Zimmer Biomet Holdings, INC. | $125.89 | 2019-2021 | |
| Depuy Synthes Products, INC. | $88.54 | 2023 | Fibergraft Aeridyan Matrix, Fibergraft Bg Morsels |
| Ethicon US, LLC | $46.26 | 2020-2021 | |
| Si-Bone, INC. | $28.99 | 2022 | |
| Globus Medical, INC. | $21.70 | 2025 | Anthem |
| Djo, LLC | $20.61 | 2019 | |
| Amgen INC. | $16.21 | 2024 | Evenity, Prolia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Koerner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.